Pharmaceutical Lipids Market - Global Industry Analysis, Growth, Key Trends, Regional Assessment and Forecast 2019 - 2029

  • Single User License $3500

Pharmaceutical Lipids Market - Global Industry Analysis, Growth, Key Trends, Regional Assessment and Forecast 2019 - 2029

Status : October, 2020 | Pharmaceutical | PPT format

Report Digest


Pharmaceutical Lipids Market: Overview

Chronic and viral diseases continue to cast their ugly shadow on the world with high transmission rates and increasing fatalities. To bring down the rate of fatalities and provide effective treatment through cutting-edge drugs is an essential factor. Lipids play an important role in the drug delivery process. Therefore, based on this aspect, the pharmaceutical lipids market may gain considerable momentum over the forecast period of 2019-2029. The growing threat of the novel coronavirus disease may bring exponential growth for the pharmaceutical lipids market.

On the basis of product, the pharmaceutical lipids market can be classified into sphingolipids, cholesterol, fatty acids, triglycerides, and phospholipids. Hospitals, pharmacies, retail stores, and drug stores are categorized as distribution channels of the pharmaceutical lipids market.

This pharmaceutical lipids market report analyses diverse factors that are associated with bringing growth. Some major aspects such as emerging trends, mergers and acquisitions, and the geographical dimensions of the pharmaceutical lipids market have been thoroughly studied in this report. The stakeholders can gain good advantage from this report on the pharmaceutical lipids market. Furthermore, this report also carries an analysis of the COVID-19 impact on the pharmaceutical lipids market.

Pharmaceutical Lipids Market: Competitive Aspects

The intensified competition from a plethora of local and international players in the pharmaceutical lipids market places it under a fragmented landscape. The players in the pharmaceutical lipids market are constantly involved in research and development activities for the exploration of new formulations that can treat various diseases.

The COVID-19 outbreak has brought tremendous loss to the global populace with increasing infections and high fatality rates. Thus, many biopharma firms have braced themselves for finding an effective treatment for COVID-19. Lipids form an important component in the formulation of an efficient treatment option. Therefore, the demand for lipids has gone up and is eventually proving to be a boon for the pharmaceutical lipids market.

Some key participants in the pharmaceutical lipids market are Esperion Therapeutics, Avanti Polar Lipids, Cayman Chemical, Cerbios-Pharma, CordenPharma International, Sancilio & Company, and VAV Life Sciences Merck.

Pharmaceutical Lipids Market: Mergers and Acquisitions

Mergers, acquisitions, partnerships, collaborations, and joint ventures bring immense growth opportunities for the pharmaceutical lipids market. These activities also help in strengthening the foothold of the players in the pharmaceutical lipids market. Here are some recent mergers and acquisitions in the pharmaceutical lipids market.

  • Croda International announced to acquire Avanti Polar Lipids for $185 mn, plus an additional; $75 mn depending on financial performance.
  • Abitec Corporation recently acquired Larodan AB, a manufacturer of high purity research-grade lipids.
  • CordenPharma extended the agreement with Moderna Inc. to supply lipids required for producing Moderna’s COVID-19 vaccine candidate

Pharmaceutical Lipids Market: Key Trends

 The development of a COVID-19 vaccine is in clinical trial phase and numerous pharmaceutical companies have joined the race with their vaccine candidates. Pharmaceutical lipids may observe escalating demand from the companies in the race for finding an effective COVID-19 treatment. Therefore, this factor brings immense growth prospects for the pharmaceutical lipids market.

Lipids are also gaining substantial demand for developing cancer drug delivery systems. For instance, Cellectar Biosciences is examining the potential of CLR 131, a phospholipid drug-conjugate to cure cancer. It has shown efficacy in treating B-cell malignancies, including multiple myeloma. Such developments bring prodigious growth for the pharmaceutical lipids market.

Pharmaceutical Lipids Market: Geographical Insights

The pharmaceutical lipids market is geographically segmented into Europe, Latin America, the Middle East and Africa, Europe, and North America. Asia Pacific may help the pharmaceutical lipids market to flutter its wings across the horizon of growth due to a substantial presence of API manufacturers in the region. The swelling number of chronic diseases may also bring extensive growth opportunities for the pharmaceutical lipids market.

This study provides a particularized anatomy according to the L.E.A.P mechanism

  • Latest trends and cardinal growth prospects
  • Existing and future insights in growth
  • Ascensions in technology
  • Pain points

The regional analysis offers market assays across:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study, prepared through the L.E.A.P mechanism adds a dimension of infallibility and assures precise information on all the growth dynamics.

Latest Trends and Cardinal Growth Prospects

The study assists in burnishing the knowledge of the stakeholder in terms of the emerging trends. The study provides an expansive coverage on the latest developments and novel profit-yielding sources that augur well with the market. A dedicated and determined team of experts conduct an out-and-out research on diverse aspects to offer ultimate breakthroughs in the market.

Existing and Future Insights in Growth

The interfusion of ubiquitous primary and secondary research through modern tools invites perfection and accuracy in every aspect. Primary research is circumspectly conducted through exhaustive interactions and interviews of experts. These valuable opinions are then neatly inducted in the report to allow the stakeholder for reaping the benefits. A treasure of secondary data is extracted via famed paid sources, yearly estimates and statements, renowned journals, and government documents. These sources assist in creating a robust database comprising existing and subsequent growth dynamics.

Ascensions in Technology

Diverse technological advancements and cutting-edge innovations in the market have been covered in this study to assist the stakeholder in research and development activities. Recent upgrades have also been added in the study, thus helping the stakeholder to paint the strokes of growth on the canvas of the market.

Pain Points

The study presents a plethora of challenges and obstacles that can hinder the growth of the market to allow the stakeholder to prepare their strategies accordingly.

The world ushered in the new decade with the shadow of the COVID-19 pandemic. The outbreak has damaged the growth prospects of several businesses and has crippled the entire economy. The study is in tandem with the changing dynamics of the market due to the SARS-CoV-2 outbreak. The study focuses on the coronavirus pandemic and analyses every aspect that impacts the growth positively or negatively.

An aerial perspective of the regions covered in this study enables the stakeholder to design strategies accordingly. The 360-degree assessment of every aspect associated with growth offers information on a rainbow of growth opportunities available across the market.

The exhaustive study motivates the stakeholder to take the 'LEAP' of faith and achieve success!

This report is the key to questions such as:

What are the prominent factors that will help in reshaping the market growth?

Which trends have the potential to bring expansive growth for the market?

What are the necessary strategies to overcome the ill-effects of the COVID-19 pandemic?

Which regions will emerge as champion growth contributors for the market?

Which aspects will serve as game-changers for the market?

What are the latest innovations in the market?

Which factors will hinder the growth of the market?